GHK-Cu: The Copper Peptide for Skin and Tissue Regeneration

GHK-Cu: The Copper Peptide for Skin and Tissue Regeneration

From Peptidepedia, the trusted peptide wiki.

Clinical Pharmacist

Key Takeaways

GHK-Cu is a natural copper peptide often used for skin repair, wound healing, and hair support.

It may work by helping the body make more collagen and elastin while also lowering inflammation.

GHK-Cu is not FDA-approved for medical use, is not currently banned by WADA, and is often sold as a research or cosmetic product.

GHK-Cu (copper peptide) combines glycine, histidine, and lysine with a copper ion. The compound exhibits regenerative properties including wound healing, skin rejuvenation, hair growth stimulation, and anti-inflammatory effects. Common injectable protocols use 0.5–1 mg daily via subcutaneous injection, or topical formulations are applied once or twice daily, with cycles lasting 4–12 weeks. Users include anti-aging enthusiasts, biohackers, athletes, and those seeking enhanced tissue repair.

Primary benefits include:

Accelerated wound healing

Reduced fine lines and wrinkles

Increased collagen and elastin synthesis

Hair follicle stimulation (see our [best peptides for hair growth guide](/guides/best-peptides-for-hair-growth))

Anti-inflammatory action

Potential neuroprotective effects

What Is GHK-Cu?

GHK-Cu, formally glycyl-L-histidyl-L-lysine copper complex, is a naturally occurring peptide first identified in human plasma in 1973 by Dr. Loren Pickart. This tripeptide exists endogenously in blood, saliva, and urine, with plasma concentrations declining significantly with age.

The peptide regulates numerous genes involved in tissue remodeling and repair. Computational analysis using the Connectivity Map database (Pickart, PMC6073405) identified that GHK-Cu may modulate the expression of over 4,000 human genes. This figure comes from a bioinformatic database query, not direct experimental measurement in human tissue. Computational analyses (Connectivity Map) have shown that GHK has the potential to influence gene expression patterns in diseased cell models from cancer and COPD patients toward healthier profiles.

How It Works

Collagen and Extracellular Matrix Remodeling

GHK-Cu stimulates synthesis of collagen types I and III, elastin, proteoglycans, and glycosaminoglycans. It simultaneously stimulates matrix metalloproteinases (MMPs) expression while promoting tissue inhibitors of metalloproteinases (TIMPs). This dual action favors tissue regeneration and structural integrity.

Anti-Inflammatory and Antioxidant Mechanisms

GHK-Cu demonstrates significant anti-inflammatory properties by modulating cytokine expression. It reduces pro-inflammatory markers including TNF-α, IL-6, and TGF-β while promoting anti-inflammatory responses. The copper ion component provides antioxidant benefits as a cofactor for superoxide dismutase (SOD), neutralizing reactive oxygen species (ROS).

Gene Expression Modulation

GHK-Cu can reset gene expression patterns associated with disease and tissue damage toward those more characteristic of healthy tissue. The peptide upregulates genes involved in stem cell proliferation, DNA repair, and antioxidant responses while downregulating genes associated with inflammation, tissue destruction, and cancer metastasis.

Copper Delivery and Angiogenesis

The copper ion serves multiple biological functions beyond antioxidant activity. Copper is essential for angiogenesis (new blood vessel formation), critical for wound healing and tissue regeneration. GHK-Cu facilitates copper delivery to tissues, supporting lysyl oxidase activity necessary for collagen and elastin cross-linking.

“GHK-Cu is unusual among peptides in that its copper ion isn't just a structural component — it actively drives enzymatic processes like superoxide dismutase activity and lysyl oxidase-mediated collagen cross-linking, giving it a dual role as both a signaling molecule and a cofactor delivery system.”

Dosage Protocols

No FDA-approved dosing guidelines exist for GHK-Cu. The following protocols are derived from preclinical research and community reports:

For subcutaneous injection, conservative dosage starts at 0.5 mg once daily. Note: to date, human studies use topical administration, not subcutaneous. All injectable dosing is extrapolated from preclinical data and community use.

Cycling is sometimes recommended to prevent receptor desensitization. An example cycle consists of 4-8 weeks of daily administration followed by 2-4 week breaks. Some users extend cycles to 12 weeks for significant wound healing or hair restoration.

Starting dose: 0.5 mg once daily subcutaneously

Standard dose: 0.5-1 mg once daily

Localized concerns: 0.5 mg daily, combined with topical application to target areas

Anti-aging skin protocol: Some practitioners recommend 2-3 times weekly rather than daily

Begin with the minimum effective dose and adjust based on observed results and tolerance. Individual responses vary.

How to Use / Administration Methods

Subcutaneous Injection: Injections are typically administered in the abdominal area, rotating injection sites to prevent tissue irritation. Using an insulin syringe (29-31 gauge), inject into the subcutaneous fat layer at a 45-90 degree angle. Most users prefer morning administration.

Topical Application: Available in creams, serums, and solutions. Concentrations typically range from 0.1%-1%. Topical use is effective for localized skin concerns but provides limited systemic benefits. Apply to clean, dry skin once or twice daily.

Mesotherapy/Microneedling: Some practitioners combine GHK-Cu with microneedling procedures to enhance penetration and stimulate additional collagen production. Particularly popular for facial rejuvenation and scar treatment.

Intradermal Injection: For targeted treatment of scars, wrinkles, or hair loss, small amounts can be injected directly into affected areas. Requires proper training and sterile technique.

Results Timelines

Important: The timelines below are based on topical use and anecdotal reports. There are zero published human clinical trials for subcutaneous GHK-Cu injection. All human clinical evidence for GHK-Cu is exclusively from topical application. Injectable timelines are entirely extrapolated from preclinical animal data and community reports, not controlled human research.

Weeks 1-2:

Initial improvements in skin hydration and texture may appear with topical use

Some users report a subtle "glow" or improved skin tone

Wound healing acceleration becomes apparent

Animal studies showed some wounds heal completely within 14 days

Weeks 3-4:

More noticeable improvements in skin firmness and elasticity

Fine lines may soften

Users recovering from injuries often report significant tissue repair progress

In animal models, effects on collagen and extracellular matrix accumulation are measurable

Weeks 6-8:

Substantial improvements in skin quality may become visible, including wrinkle depth reduction and improved overall appearance

Weeks 8-12:

Maximum benefits typically manifest during extended cycles

Significant collagen remodeling, scar improvement, and hair density increases are commonly reported

Results vary considerably based on age, baseline skin condition, dosage, and consistency of use. Photographic documentation is recommended for objective tracking.

Research Evidence

Scientific literature spans several decades with in vitro and in vivo studies. Research published in the Journal of Biomaterials Science showed that GHK-Cu significantly accelerates wound healing by promoting fibroblast proliferation and collagen synthesis.

A comprehensive review in Biomed Research International reported GHK-Cu's potential to modulate over 4,000 genes related to aging and tissue repair, based on Connectivity Map computational analysis rather than direct experimental measurement in human tissue. The study highlighted potential applications in treating age-related conditions and promoting healthy aging.

Key findings from the research literature include:

Stimulation of collagen I, III, elastin, and glycosaminoglycan synthesis in fibroblasts and skin models

Modulation of pro-inflammatory cytokines (TNF-α, IL-6, TGF-β) toward anti-inflammatory outcomes

Upregulation of antioxidant defense genes via copper-dependent SOD activity

Acceleration of wound re-epithelialization and granulation tissue formation in animal wound models

Hair follicle enlargement and stimulation of follicle growth in rodent models

The majority of research remains preclinical. Large-scale human clinical trials are absent, which is a significant limitation when drawing conclusions about efficacy and safety in humans.

“The Connectivity Map gene expression data is compelling but should be interpreted carefully — computational predictions of gene modulation are hypothesis-generating, not confirmatory. What we can say with confidence is that the preclinical wound healing and collagen synthesis data is robust and mechanistically well-understood.”

Stacking

As of 2026, there is no research to support stacking, but GHK-Cu is frequently combined with other peptides:

GHK-Cu + BPC-157

Popular for accelerated healing, as both peptides promote tissue repair through complementary mechanisms. BPC-157 addresses gut and tendon healing while GHK-Cu provides systemic regenerative support. See our GHK-Cu vs BPC-157 comparison for a detailed breakdown.

GHK-Cu + TB-500 (Thymosin Beta-4)

A healing-focused stack combining TB-500's cell migration and blood vessel formation properties with GHK-Cu's collagen-stimulating effects.

GHK-Cu + Epithalon

For comprehensive anti-aging protocols, GHK-Cu paired with epithalon may appeal to those seeking to support youthful appearance and longevity-related gene expression.

GHK-Cu + Growth Hormone Secretagogues

Some users combine GHK-Cu with peptides like Ipamorelin or CJC-1295 for synergistic recovery benefits.

When stacking, introduce one compound at a time to assess individual responses before combining multiple peptides.

Reconstitution, Storage & Prep

Reconstitution: Use bacteriostatic water (BAC water) for reconstitution. Inject water slowly along the vial's inner wall, allowing powder to dissolve naturally. Do not shake vigorously.

Storage:

Unreconstituted GHK-Cu should be stored in a cool, dry place away from light

Refrigeration extends shelf life but is not strictly required for short-term storage

Once reconstituted, store in refrigerator at 2-8°C (36-46°F) and use within 4-6 weeks

Preparation: Before injection, allow vial to reach room temperature. Clean vial stopper and injection site with alcohol swabs. Draw appropriate dose using an insulin syringe, removing air bubbles before administration.

Side Effects

GHK-Cu demonstrates an excellent safety profile with minimal reported adverse effects. Most common side effects include:

Mild injection site reactions (redness, swelling, or itching)

Temporary skin flushing

Occasional headache

Serious adverse effects are rare. Individuals with copper metabolism disorders (such as Wilson's disease) should avoid GHK-Cu supplementation. Those with active cancer should consult healthcare providers before use, as the peptide's growth-promoting properties warrant caution.

Allergic reactions are uncommon but possible. Discontinue use if significant swelling, difficulty breathing, or severe skin reactions occur.

“The favorable safety profile of GHK-Cu is consistent with what we'd expect from an endogenous peptide — the body already produces and metabolizes it. The primary safety concern remains individuals with copper homeostasis disorders like Wilson's disease, where any exogenous copper source can be clinically significant.”

Legal Status / FDA

GHK-Cu is not FDA-approved for any medical indication in the United States. It is classified as a research chemical and legally available for purchase for research purposes. The peptide is not a controlled substance and can be legally possessed in most jurisdictions.

Topical GHK-Cu products are available as cosmetic ingredients and widely used in skincare formulations without regulatory restriction. Note that topical cosmetic products are regulated differently from injectable forms; only injectable use falls into the research-chemical gray area.

Key Regulatory Points:

Not FDA-approved for any medical indication

Classified as a research chemical; legally purchasable for research purposes

Not a controlled substance; legal to possess in most jurisdictions

Topical formulations widely available as cosmetic ingredients

Quality and purity vary significantly between suppliers, making source verification essential

Users should understand that purchasing GHK-Cu for personal use exists in a regulatory gray area. For guidance on vetting suppliers, see our [peptide purity testing guide](/guides/peptide-purity-testing).

Sports / WADA

GHK-Cu is not currently listed on the World Anti-Doping Agency (WADA) Prohibited List. However, athletes subject to drug testing should exercise caution, as anti-doping regulations evolve and peptides face increasing scrutiny.

The peptide's healing and recovery properties make it attractive to athletes, but competitive athletes should verify current regulations with their governing bodies before use.

Conclusion

GHK-Cu is one of the more versatile peptides available for regenerative applications. Its natural occurrence in the human body, combined with a strong safety record and broad therapeutic potential, makes it an attractive option for those seeking enhanced tissue repair, anti-aging benefits, and overall regenerative support.

The peptide's ability to modulate thousands of genes toward healthier expression patterns distinguishes it from single-mechanism compounds. Whether used for wound healing, skin rejuvenation, hair restoration, or general anti-aging, GHK-Cu offers an approach with evolving scientific support.

As with any peptide, sourcing from reputable suppliers, following proper reconstitution and storage protocols, and starting with conservative doses are essential practices for safe and effective use.

Frequently Asked Questions

Initial improvements in skin texture and hydration may appear within 2-3 weeks. More significant results, including wrinkle reduction and hair growth, typically require 6-12 weeks of consistent use.

Yes, GHK-Cu is generally compatible with most skincare ingredients. When using topical GHK-Cu, it can be layered with retinoids, vitamin C, and other actives. Some users report enhanced results when combining these treatments.

Current evidence suggests GHK-Cu has an excellent safety profile for extended use. However, cycling (periods of use followed by breaks) is recommended to maintain receptor sensitivity and optimize results.

Injectable GHK-Cu may provide systemic benefits, while topical application primarily affects the local application area. More research is needed in these areas.

Research indicates GHK-Cu can stimulate hair follicle growth and may be beneficial for certain types of hair loss. Results may require 3-6 months of consistent use and vary based on the underlying cause of hair loss.

While not strictly required, cycling is recommended to prevent potential receptor desensitization. Common protocols include 4-8 weeks on followed by 2-4 weeks off.

Seek suppliers providing third-party purity testing (HPLC analysis), proper storage and shipping conditions, and transparent sourcing information. Purity should be 98% or higher.

GHK-Cu is sometimes combined with peptides like BPC-157 and TB-500, as well as anti-aging peptides like epithalon. Introduce compounds individually to assess tolerance before combining.

This content is for educational and informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making any health-related decisions.

References

Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.

Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988.

Canapp SO Jr, et al. The anti-inflammatory effect of the naturally occurring peptide GHK. Veterinary Surgery. 2003;32(4):391-396.

Pickart L, Margolina A. Skin Regenerative and Anti-Cancer Actions of Copper Peptides. Cosmetics. 2018;5(2):29.

Kang YA, et al. Copper-GHK increases integrin expression and p63 positivity by keratinocytes. Archives of Dermatological Research. 2009;301(4):301-306.

Siméon A, et al. Expression of glycosaminoglycans and small proteoglycans in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. Journal of Investigative Dermatology. 2000;115(6):962-968.

See Related Peptides

SS-31 (Elamipretide)

SS-31 (Elamipretide) targets mitochondria to boost cellular energy and reduce oxidative stress. Dosing ranges from 4–40 mg daily via injection, showing improvements in exercise, cardiac function, and muscle strength within weeks.

BPC-157

BPC-157 is a synthetic peptide derived from stomach juice that may accelerate healing. Learn about uses, dosage protocols, side effects, legal status, and research evidence.

Related Guides

Best Peptides for Skin Health

Compare the best peptides for skin health, anti-aging, collagen production, and wound healing. Evidence-based guide to GHK-Cu, BPC-157, KPV, and more.

Best Peptides for Anti-Aging

Compare the best anti-aging peptides for longevity, skin health, cognitive function, and cellular repair. Evidence-based guide to Epithalon, SS-31, GHK-Cu, and more.

Peptide Purity Testing

Learn how to verify peptide purity using HPLC, mass spectrometry, and third-party lab testing. Understand Certificates of Analysis, common impurities, and what purity standards to look for.